About Lumos Diagnostics
Lumos Diagnostics is a company based in Carlsbad (United States) founded in 2017.. Lumos Diagnostics has raised $40 million across 2 funding rounds from investors including Planet Innovation, Perennial Partners and Ellerston Capital. Lumos Diagnostics operates in a competitive market with competitors including Access Bio, SD Biosensor, Fluxergy, Module Innovations and DxGen, among others.
- Headquarter Carlsbad, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lumos Diagnostics Holdings Limited
-
Annual Revenue
$12.65 M (USD)12.72as on Jun 30, 2025
-
Net Profit
$-7.33 M (USD)15.41as on Jun 30, 2025
-
EBITDA
-
Total Equity Funding
$40 M (USD)
in 2 rounds
-
Latest Funding Round
$25 M (USD), Series B
Oct 06, 2020
-
Investors
Planet Innovation
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Lumos Diagnostics
Lumos Diagnostics is a publicly listed company on the ASX with ticker symbol LDX in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Lumos Diagnostics
Lumos Diagnostics has successfully raised a total of $40M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $25 million completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $25.0M
-
First Round
First Round
(05 Feb 2020)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2020 | Amount | Series B - Lumos Diagnostics | Valuation | Ellerston Capital , Perennial |
|
| Feb, 2020 | Amount | Series A - Lumos Diagnostics | Valuation | Planet Innovation |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Lumos Diagnostics
Lumos Diagnostics has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Planet Innovation, Perennial Partners and Ellerston Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified investment management services are provided by Ellerston Capital.
|
Founded Year | Domain | Location | |
|
Diversified asset management services are provided in Australia.
|
Founded Year | Domain | Location | |
|
End-to-end healthtech product development and manufacturing services are offered.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lumos Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Lumos Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lumos Diagnostics Comparisons
Competitors of Lumos Diagnostics
Lumos Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Access Bio, SD Biosensor, Fluxergy, Module Innovations and DxGen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
In vitro rapid diagnostic tests, biosensor, and molecular diagnostic products for diagnosis of infectious diseases.
|
|
| domain | founded_year | HQ Location |
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
|
|
| domain | founded_year | HQ Location |
Provides diagnostic devices and software for clinical and veterinary point-of-care testing.
|
|
| domain | founded_year | HQ Location |
Diagnostics strip for bacterial detection
|
|
| domain | founded_year | HQ Location |
Point-of-care diagnostic products for diabetes and tuberculosis are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lumos Diagnostics
Frequently Asked Questions about Lumos Diagnostics
When was Lumos Diagnostics founded?
Lumos Diagnostics was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Where is Lumos Diagnostics located?
Lumos Diagnostics is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
Who is the current CEO of Lumos Diagnostics?
Sacha Dopheide is the current CEO of Lumos Diagnostics.
Is Lumos Diagnostics a funded company?
Lumos Diagnostics is a funded company, having raised a total of $40M across 2 funding rounds to date. The company's 1st funding round was a Series A of $15M, raised on Feb 05, 2020.
What is the annual revenue of Lumos Diagnostics?
Annual revenue of Lumos Diagnostics is $12.65M as on Jun 30, 2025.
What does Lumos Diagnostics do?
Lumos Diagnostics offer a range of diversified diagnostic products. Lumos platform includes assays, readers, cartridges, and software. Their assays include lateral flow and microfluidics to immunoassay and molecular methodologies. Lumos develops disposable assays suitable for assay test strips and development of custom assay specific analysis algorithms. Th company also has handheld and benchtop readers. The company makes POC cartridge technologies, from lateral flow through to microfluidics. The company has a cloud platform capturing information on device location, test usage, results and associated patient metrics.
Who are the top competitors of Lumos Diagnostics?
Lumos Diagnostics's top competitors include Access Bio, SD Biosensor and Module Innovations.
Is Lumos Diagnostics publicly traded?
Yes, Lumos Diagnostics is publicly traded on ASX under the ticker symbol LDX.
Who are Lumos Diagnostics's investors?
Lumos Diagnostics has 3 investors. Key investors include Planet Innovation, Perennial Partners, and Ellerston Capital.
What is Lumos Diagnostics's ticker symbol?
The ticker symbol of Lumos Diagnostics is LDX on ASX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.